Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
Mulgaonkar S, Tedesco H, Oppenheimer F, Walker R, Kunzendorf U, Russ G, Knoflach A, Patel Y, Ferguson R; FTYA121 study group. Mulgaonkar S, et al. Among authors: oppenheimer f. Am J Transplant. 2006 Aug;6(8):1848-57. doi: 10.1111/j.1600-6143.2006.01404.x. Epub 2006 Jun 12. Am J Transplant. 2006. PMID: 16771816 Free article. Clinical Trial.
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial.
Wlodarczyk Z, Squifflet JP, Ostrowski M, Rigotti P, Stefoni S, Citterio F, Vanrenterghem Y, Krämer BK, Abramowicz D, Oppenheimer F, Pietruck F, Russ G, Karpf C, Undre N. Wlodarczyk Z, et al. Among authors: oppenheimer f. Am J Transplant. 2009 Nov;9(11):2505-13. doi: 10.1111/j.1600-6143.2009.02794.x. Epub 2009 Aug 14. Am J Transplant. 2009. PMID: 19681813 Free article. Clinical Trial.
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M; ELEVATE Study Group. de Fijter JW, et al. Among authors: oppenheimer f. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14. Am J Transplant. 2017. PMID: 28027625 Free article. Clinical Trial.
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
Salvadori M, Rosati A, Bertoni E, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Soergel M. Salvadori M, et al. Among authors: oppenheimer f. Transplant Proc. 2006 May;38(4):1010-3. doi: 10.1016/j.transproceed.2006.03.060. Transplant Proc. 2006. PMID: 16757247
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J. Gonzalez Molina M, et al. Among authors: oppenheimer f. Transplant Proc. 2007 Sep;39(7):2167-9. doi: 10.1016/j.transproceed.2007.07.043. Transplant Proc. 2007. PMID: 17889126
341 results